ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGLS Regulus Therapeutics Inc

2.13
-0.09 (-4.05%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.09 -4.05% 2.13 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.23 2.09 2.31 2.13 2.22
more quote information »

Recent News

Date Time Source Heading
3/21/202416:05PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
3/12/202406:32PRNUSRegulus Therapeutics Announces Oversubscribed $100 Million..
3/12/202406:30PRNUSRegulus Therapeutics Announces Positive Topline Data from..
1/18/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/12/202416:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/10/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/02/202416:05PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
12/27/202316:16EDGAR2Form S-3 - Registration statement under Securities Act of..
11/22/202308:00PRNUSRegulus Therapeutics to Present at the 6th Annual Evercore..
11/09/202316:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:15EDGAR2Form 8-K - Current report
11/09/202316:05PRNUSRegulus Therapeutics Reports Third Quarter 2023 Financial..
11/02/202308:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Third..
10/19/202308:00PRNUSRegulus Therapeutics Advances to Cohort 3 of Phase 1b..
9/20/202307:00PRNUSRegulus Therapeutics Announces Positive Topline Data from..
9/13/202308:00PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
9/05/202308:00PRNUSRegulus Therapeutics Announces Participation at Two..
8/23/202308:00PRNUSRegulus Therapeutics to Host Virtual Investor Event on..
8/14/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202316:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:15EDGAR2Form 8-K - Current report
8/08/202316:05PRNUSRegulus Therapeutics Reports Second Quarter 2023 Financial..
8/02/202308:00PRNUSRegulus Therapeutics to Present at the Canaccord Genuity..
7/18/202308:00PRNUSRegulus Therapeutics to Present at the H.C. Wainwright 2nd..
6/29/202316:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
6/27/202308:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Second..
6/23/202308:00PRNUSRegulus Therapeutics Announces Appointment of Preston S...
6/20/202308:00PRNUSRegulus Therapeutics Announces Update on Preclinical Studies..
6/12/202308:00PRNUSRegulus Therapeutics Strengthens Research & Development..
5/16/202308:00PRNUSRegulus Therapeutics Advances to Cohort 2 of Phase 1b..
5/11/202316:05PRNUSRegulus Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock